What is it?
What fenugreek is
3Fenugreek is the seed of Trigonella foenum-graecum, a Fabaceae plant used as a spice, food ingredient, traditional herb, seed powder, and standardized extract. Its maple-like odor comes from volatile compounds, while supplement interest usually centers on fiber, saponins, trigonelline, 4-hydroxyisoleucine, and diosgenin-related constituents.
Names, aliases and forms
Mechanisms of action
Fiber, saponins, and seed constituents
3Fenugreek seed fiber may slow carbohydrate absorption, while saponins, trigonelline, 4-hydroxyisoleucine, diosgenin-related compounds, and flavonoids are often discussed for metabolic or hormone-related effects. The exact active mix differs across whole seed, powder, extract, and branded formulations.
Potential effects and evidence map
Human evidence is most developed for glucose and lipid markers in diabetes or prediabetes, with substantial variation in product form, dose, and study quality. Standardized-extract studies in men report mixed libido or testosterone-marker outcomes. No direct human cognitive benefit is established; lactation, dysmenorrhea, and equivalence between powder and extracts remain uncertain.
Small standardized-extract trials in men report libido or testosterone-marker outcomes over several weeks.
No reliable general energy or exercise-performance benefit is established.
No reliable mood benefit was found; one libido study explicitly reported no mood effect.
Typical dosages and timing
A 6-week trial in healthy men used 600 mg/day of a standardized extract. This is a formulation-specific study dose, not a general fenugreek or seed-powder dose.
LiverTox describes diabetes and hypercholesterolemia study doses ranging from 2 to 100 grams daily in divided doses as capsules or tea. Bulk powder listings therefore need serving-size and tolerability review rather than simple price-per-gram math.
Timing & effect horizon
Safety, side effects and risk profile
NCCIH states fenugreek above food amounts is unsafe during pregnancy, while lactation evidence is mixed and safety above food amounts remains poorly defined.
Diarrhea, nausea, bloating, flatulence, and other digestive symptoms are practical dose-limiting concerns, especially with seed powder and larger doses.
High doses may lower blood sugar, and warfarin interaction reports make glucose-lowering and anticoagulant contexts relevant.
Standardized extracts can affect testosterone-related endpoints in some male studies, but these findings do not establish effects or safety across all populations or products.
Large doses may contribute to low-blood-sugar symptoms; serious allergic reactions can also occur in susceptible people.
LiverTox rates fenugreek as an unlikely cause of clinically apparent liver injury, but high-dose multi-ingredient stacks still need caution.
In the United States, dietary supplements are not FDA-approved for safety or effectiveness before sale; manufacturers are responsible for compliance.
Evidence is strongest for metabolic markers and extract-specific male outcomes; cognition, lactation, dysmenorrhea, and product equivalence remain uncertain.
Supplemental amounts above food use are not considered safe during pregnancy. In lactation, findings are mixed and safety at supplemental amounts remains poorly defined.
Large supplemental doses may lower blood sugar. This is a relevant interaction context for people using insulin or other glucose-lowering medicines, not a general benefit claim.
Nausea, diarrhea, bloating, flatulence, and maple-like body odor are practical dose-limiters. LactMed notes possible cross-reaction with chickpeas, peanuts, and other legumes in susceptible people.
Interactions and cautions
LactMed reports that fenugreek can interact with warfarin to cause bleeding. Evidence for other antiplatelet interactions is less direct, so this remains a targeted caution rather than an established effect for every product.
Legal and regulatory status
United States (FDA, as of 2026): oral fenugreek products marketed as dietary supplements are not FDA-approved for safety, effectiveness, or labeling before sale. Manufacturers are responsible for compliance, and disease-treatment claims can change the regulatory category.
Practical buying and quality notes
- Indexed rows include NOW-style 500 mg capsules, NootropicsDepot 500 mg extract capsules, BulkSupplements organic powder, BulkSupplements extract powder, and older legacy powder rows. A 500 mg capsule, a whole-seed powder scoop, and an extract standardized to saponins or 4-hydroxyisoleucine are not interchangeable.
- Useful labels specify seed versus extract, serving size, extract ratio, standardization marker, allergen handling, organic status, heavy metals, microbial testing, and lot-specific COA. Maple-like odor is expected, but rancid smell, moisture, clumping, or missing serving data should lower confidence.15
FAQ
Is fenugreek a nootropic?
2Not in the usual focus or memory sense. Human evidence is mainly metabolic, lactation, dysmenorrhea, Parkinson adjuvant, and male sexual-function research, not healthy-user cognition.
What is the fenugreek dose?
7For one standardized extract, 600 mg/day was used for 6 weeks in a healthy-male study. Whole-seed and powder studies have used broader gram-level amounts, so these forms should not be considered interchangeable.
Can fenugreek help blood sugar?
5A meta-analysis in adults with type 2 diabetes or prediabetes reported changes in several glucose markers, but the underlying trials differed in dose, form, and quality. That evidence does not establish a general effect in healthy users.
Can fenugreek increase milk supply?
3LactMed reports mixed findings for milk-supply outcomes and limited safety information at supplemental amounts. Results from combination products do not establish an effect for fenugreek alone.
Who should avoid fenugreek?
2Higher-risk contexts include supplemental amounts during pregnancy, concurrent glucose-lowering or anticoagulant medicines, and a history of serious legume allergy. Dose and product form also matter.
References
- NCBI Taxonomy. Trigonella foenum-graecum, Taxonomy ID 78534. Accessed 2026-07-01.
- NCCIH. Fenugreek: Usefulness and Safety. Last updated February 2025.
- LactMed. Fenugreek. Drugs and Lactation Database. Last revision July 15, 2026.
- LiverTox. Fenugreek. Updated January 29, 2018.
- Kim J, et al. The Effect of Fenugreek in Type 2 Diabetes and Prediabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Int J Mol Sci. 2023.
- Gong J, et al. Effect of fenugreek on hyperglycaemia and hyperlipidemia in diabetes and prediabetes: a meta-analysis. J Ethnopharmacol. 2016.
- Steels E, et al. Physiological aspects of male libido enhanced by standardized Trigonella foenum-graecum extract and mineral formulation. Phytother Res. 2011.
- Rao A, et al. Testofen seed extract reduces age-related symptoms of androgen decrease, increases testosterone levels and improves sexual function in healthy aging males. Aging Male. 2016.
- Mansoori A, et al. Effect of fenugreek extract supplement on testosterone levels in male: A meta-analysis of clinical trials. Phytother Res. 2020.
- Lee-Ødegård S, Gundersen TE, Drevon CA. Effect of a plant extract of fenugreek (Trigonella foenum-graecum) on testosterone in blood plasma and saliva in a double blind randomized controlled intervention study. PLoS One. 2024.
- Foong SC, et al. Oral galactagogues for increasing breast milk production in mothers of non-hospitalised term infants. Cochrane Database Syst Rev. 2020.
- Hassanzadeh R, et al. The Effect of Fenugreek on the Severity of Dysmenorrhea: A Systematic Review and Meta-analysis. Curr Drug Res Rev. 2024.
- Ouzir M, et al. Toxicological properties of fenugreek (Trigonella foenum graecum). Food Chem Toxicol. 2016.
- Nathan J, et al. Efficacy and safety of standardized extract of Trigonella foenum-graecum seeds as an adjuvant to L-Dopa in Parkinson disease. Phytother Res. 2014.
- U.S. Food and Drug Administration. FDA 101: Dietary Supplements. Accessed 2026-08-20.